Interested in promotions? | Click here >>
PathScan® Phospho-EGF Receptor (Tyr1068) (E746-A750del Specific) Sandwich ELISA Kit

PathScan® Phospho-EGF Receptor (Tyr1068) (E746-A750del Specific) Sandwich ELISA Kit #7702

Citations (0)
other Image 1 - PathScan® Phospho-EGF Receptor (Tyr1068) (E746-A750del Specific) Sandwich ELISA Kit

Figure 1. Constitutive phosphorylation of EGF receptor (E746-A750del) mutant protein in HCC827 cells lysed in the presence of phosphatase inhibitors* (phospho lysates) is detected by the PathScan® Phospho-EGF Receptor (Tyr1068) (E746-A750del Specific) Sandwich ELISA Kit #7702. In contrast, a low level of phospho-EGF receptor (Tyr1068) (E746-A750del) protein is detected in HCC827 cells lysed in the absence of phosphatase inhibitors* (nonphospho lysates). This kit does not detect wild type EGFR protein (phospho or nonphospho) from A-431 cells or EGFR (L858R) mutant protein (phospho or nonphospho) from H3255 cells. Absorbance at 450 nm is shown in the top figure (positive signal is seen only in HCC827 phospho lysates), while western blots using Phospho-EGF Receptor (Tyr1068) (D7A5) XP® Rabbit mAb #3777 are shown in the bottom figure. *Phosphatase inhibitors include sodium pyrophosphate, β-glycerophosphate, and Na3VO4.

other Image 2 - PathScan® Phospho-EGF Receptor (Tyr1068) (E746-A750del Specific) Sandwich ELISA Kit

Figure 2. The relationship between protein concentration of phospho or nonphospho lysates and the absorbance at 450 nm is shown. HCC827 cells were cultured (85% confluence) and lysed with or without the addition of phosphatase inhibitor to the lysis buffer (phospho or nonphospho lysate, respectively).

To Purchase # 7702

Important Ordering Details

Custom Ordering Details: When ordering five or more kits, please contact us for processing time and pricing at [email protected].

Supporting Data


Application Key:

  • W-Western
  • IP-Immunoprecipitation
  • IHC-Immunohistochemistry
  • ChIP-Chromatin Immunoprecipitation
  • IF-Immunofluorescence
  • F-Flow Cytometry
  • E-P-ELISA-Peptide

Species Cross-Reactivity Key:

  • H-Human
  • M-Mouse
  • R-Rat
  • Hm-Hamster
  • Mk-Monkey
  • Mi-Mink
  • C-Chicken
  • Dm-D. melanogaster
  • X-Xenopus
  • Z-Zebrafish
  • B-Bovine
  • Dg-Dog
  • Pg-Pig
  • Sc-S. cerevisiae
  • Ce-C. elegans
  • Hr-Horse
  • All-All Species Expected

Product Description

The PathScan® Phospho-EGF Receptor (Tyr1068) (E746-A750del Specific) Sandwich ELISA Kit is a solid phase sandwich enzyme-linked immunosorbent assay (ELISA) that detects endogenous levels of Phospho-EGF receptor (Tyr1068) (E746-A750del) mutant protein. An EGF Receptor (E746-A750del Specific) Rabbit Antibody has been coated on the microwells. After incubation with cell lysates, EGF receptor (E746-A750del) mutant protein (phospho and nonphospho) is captured by the coated antibody. Following extensive washing, a Phospho-EGF Receptor (Tyr1068) Mouse Detection Antibody is added to detect captured phosphorylated EGF receptor (E746-A750del) mutant protein. Anti-mouse IgG, HRP-linked Antibody is then used to recognize the bound detection antibody. HRP substrate, TMB, is added to develop color. The magnitude of the absorbance for this developed color is proportional to the quantity of phospho-EGF receptor (Tyr1068) (E746-A750del) mutant protein.

Antibodies in kit are custom formulations specific to kit.

Specificity / Sensitivity

PathScan® Phospho-EGF Receptor (Tyr1068) (E746-A750del Specific) Sandwich ELISA Kit #7702 detects endogenous levels of phospho-EGF receptor (Tyr1068) (E746-A750del) mutant protein in human cells, as shown in Figure 1. The kit sensitivity is shown in Figure 2. This kit detects proteins from the indicated species, as determined through in-house testing, but may also detect homologous proteins from other species.


The epidermal growth factor (EGF) receptor is a 170 kDa transmembrane tyrosine kinase that belongs to the HER/ErbB protein family. Research studies have shown that somatic mutations in the tyrosine kinase domain of EGF receptor (EGFR) are present in a subset of lung adenocarinomas that respond to EGFR inhibitors, such as gefinitib and erlotinib (1-3). Two types of mutations account for approximately 90% of mutated cases: a specific point mutation, L858R, that occurs in exon 21 and short in-frame deletions in exon 19 (4,5). The most frequent exon 19 deletion is E746-A750, accounting for 90% of lesions at this site, although some rare variants occur.

  1. Lynch, T.J. et al. (2004) N Engl J Med 350, 2129-39.
  2. Pao W et al. (2004) Proc Natl Acad Sci U S A 101, 13306–11
  3. Haber, D.A. et al. (2005) Cold Spring Harb Symp Quant Biol 70, 419-26.
  4. Kosaka, T. et al. (2004) Cancer Res 64, 8919-23.
  5. Riely, G.J. et al. (2006) Clin Cancer Res 12, 7232-41.

Pathways & Proteins

Explore pathways + proteins related to this product.

For Research Use Only. Not For Use In Diagnostic Procedures.
Cell Signaling Technology is a trademark of Cell Signaling Technology, Inc.
PathScan is a trademark of Cell Signaling Technology, Inc.